Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 442

Showing 1-25 of 442 citing articles:

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 700
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 141
The senescence-associated secretory phenotype and its physiological and pathological implications
Boshi Wang, Jin Han, Jennifer H. Elisseeff, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 12, pp. 958-978
Closed Access | Times Cited: 139
Advances in PET imaging of cancer
Johannes Schwenck, Dominik Sonanini, Jonathan Cotton, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 474-490
Closed Access | Times Cited: 105
Inflammation and DNA damage: cause, effect or both
Antonio Pezone, Fabiola Olivieri, Maria Vittoria Napoli, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 4, pp. 200-211
Closed Access | Times Cited: 97
Cardiovascular disease and cancer: shared risk factors and mechanisms
Nicholas S. Wilcox, Uri Amit, Jacob B. Reibel, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 9, pp. 617-631
Closed Access | Times Cited: 73
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Hanxin Liu, Qixia Xu, Halidan Wufuer, et al.
Aging Cell (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 71
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 55
Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Rumiana Tenchov, Janet M. Sasso, Xinmei Wang, et al.
ACS Chemical Neuroscience (2023) Vol. 15, Iss. 1, pp. 1-30
Open Access | Times Cited: 54
Kaempferol: Paving the path for advanced treatments in aging-related diseases
Md Sadique Hussain, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Experimental Gerontology (2024) Vol. 188, pp. 112389-112389
Open Access | Times Cited: 48
Lipids and lipid metabolism in cellular senescence: Emerging targets for age-related diseases
Qing Zeng, Yongzhen Gong, Neng Zhu, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102294-102294
Closed Access | Times Cited: 34
Cellular senescence: Neither irreversible nor reversible
Maurice Reimann, Soyoung Lee, Clemens A. Schmitt
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 4
Open Access | Times Cited: 33
Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Saurav Kumar Jha, Gabriele De Rubis, Shankar Raj Devkota, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102315-102315
Open Access | Times Cited: 30
Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer
Fuming Li, Pingyu Liu, Mi Wen, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 131-146
Open Access | Times Cited: 29
Cellular senescence and SASP in tumor progression and therapeutic opportunities
Zening Dong, Yahan Luo, Zhangchen Yuan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
The senescence journey in cancer immunoediting
Alessandra Zingoni, Fabrizio Antonangeli, Silvano Sozzani, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Role of cellular senescence in inflammation and regeneration
Yuki Saito, Sena Yamamoto, Takako Chikenji
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 19
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer
Jad I. Belle, D. Sen, John Baer, et al.
Cancer Discovery (2024) Vol. 14, Iss. 7, pp. 1324-1355
Closed Access | Times Cited: 18
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 11
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Li Gu, Yahui Zhu, Shuvro P. Nandi, et al.
Nature (2025) Vol. 637, Iss. 8045, pp. 461-469
Closed Access | Times Cited: 4
Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
Hyun Jung Hwang, Donghee Kang, Jisoo Shin, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 2
Tailoring traditional Chinese medicine in cancer therapy
Shuiquan Li, Xi Chen, Hui Shi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Emerging prodrug and nano-drug delivery strategies for the detection and elimination of senescent tumor cells
Tao Wang, Xianbao Shi, Xiaolong Xu, et al.
Biomaterials (2025), pp. 123129-123129
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top